Table 4.

Logistic regression of endometrial cancer risk for 39,411 breast cancer patients with tamoxifen use on duration of tamoxifen treatment, prior hormone exposure, hypertension, diabetes and age

		OR	95% CI		p-value
			Lower	Upper
Less than 3 years tamoxifen use		1.32	0.95	1.83	0.10
3 years or above of tamoxifen use		2.94	2.13	4.06	<0.001
Age above 35 years old		4.08	1.67	9.93	0.002
Prior hormone exposure		1.00	0.76	1.31	0.10
Prior hypertension		0.74	0.49	1.13	0.17
Prior diabetes		1.17	0.66	2.07	0.60